Delivery Order SPE2DB22D1106-SPE2DB25FFJG3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,154.63 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used primarily for opioid use...
- The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial with diluents. This contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of opioid and alcohol use...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Vivitrol 380 mg vial-diluents with a ceiling value of $3,862.11. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $22,966.57 delivery order for Vivitrol 380 mg vial-diluents, with a completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents, with a ceiling value of $8,844.95. This is a firm fixed price, non-set-aside contract awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,002.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents, with an ultimate completion date of June 30, 2025. This non-set-aside award was issued on June 27, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,762.71 for Vivitrol 380 mg vial-diluents on August 14, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 15, 2025 and serves the Defense Logistics Agency's Medical Supply Chain. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $4,712.97 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under...
- The Defense Logistics Agency (DLA) awarded a $2,002.34 delivery order to AmerisourceBergen Drug Corp for VIVITROL 380 MG vial-diluents on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. VIVITROL is an extended-release injectable medication used primarily for opioid use disorder treatment, making...
- The Defense Logistics Agency awarded a $2,002.34 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents, with an ultimate completion date of July 15, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFJG3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 16, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Vivitrol is an extended-release naltrexone injection used in substance use disorder treatment, representing part of AmerisourceBergen's broader pharmaceutical supply portfolio to federal healthcare systems. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor that supplies medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements through firm fixed-price delivery orders across a broad range of medical products and supply volumes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/15/25 |